Newsletter Signup | Join Community
Checkpoint inhibitor Inlyta combo now FDA approved - likely to become new standard treatment for renal cell cancer
Update on treatment progress, the new role of precision immunotherapy and ALL the approved treatments for kidney cancer.
First-Line Inlyta Active in Metastatic Kidney Cancer
Opdivo® approved by US FDA for treatment of advanced renal cell cancer.
Inlyta Approved for Advanced Kidney Cancer.
Oral Precision Cancer Medicine Votrient Improves Progression-free Survival in Advanced Kidney Cancer.
Long-Term Survival of Patients with Renal Cell Cancer After High-Dose Continuous Infusion of Interleukin-2
Updated Results Confirm Survival Benefit of Nexavar® in Renal Cell Carcinoma
Dr. Janice Dutcher (NY), Dr. Keith Flaherty (Penn) Dr. David I. Quinn (USC) discuss kidney cancer.
Bevacizumab Delays Cancer Progression in Metastatic Renal Cell Cancer
Has anyone had their kidney cancer removed by laproscope? Doctor says recovery will be much quicker.…